Lymphoma involving the testis is uncommon, accounting for 1-2% of testicular tumors. The most common type is diffuse large B-cell lymphoma (DLBCL), which accounts for 80-90% of cases and typically affects older men with a mean age of 60 years. Testicular follicular lymphoma is rare but usually occurs in children and young adults, carrying an excellent prognosis even with conservative therapy. Other types include Burkitt lymphoma, B-cell lymphoblastic leukemia/lymphoma, and rarely NK/T-cell lymphoma or plasma cell neoplasms. Differential diagnoses that can mimic lymphoma include seminoma, spermatocytic tumor, malignant teratomas, and myeloid sarcoma
The document discusses the development and benefits of the Milan System for Reporting Salivary Gland Cytopathology. It aims to standardize terminology for salivary gland FNA reports which previously lacked uniformity. The system categorizes specimens as non-diagnostic, non-neoplastic, atypia of undetermined significance, neoplastic (benign or uncertain malignant potential), suspicious for malignancy, or malignant. It is intended to improve communication between pathologists and clinicians, enhance patient care, and facilitate research by allowing standardized data collection across institutions. While validation is ongoing, the system provides a practical framework for uniform reporting of salivary gland cytology.
This document summarizes key information about major and minor salivary glands including their location and cell types. It describes common benign and malignant epithelial tumors of the salivary glands such as pleomorphic adenoma, Warthin's tumor, oncocytoma, and mucoepidermoid carcinoma. For each tumor, the clinical features, microscopic appearance, differential diagnosis, and important histological characteristics are outlined. The document provides an overview of salivary gland anatomy, histology, and the spectrum of tumors that can arise in these glands.
The document discusses recent updates in the diagnosis and grading of prostatic carcinoma, including revisions to Gleason scoring guidelines regarding lesions like cribriform and intraductal carcinoma. It also reviews the role of immunohistochemistry and molecular markers in prognostication as well as emerging applications of artificial intelligence in prostate cancer diagnosis.
The document summarizes the International Academy of Cytology (IAC) System for classifying breast malignancy based on fine-needle aspiration cytology (FNAC) results. The system was developed at a meeting in Yokohama in 2016. It aims to standardize breast cytology reporting to improve diagnosis and patient management. The system categorizes FNAC results as insufficient, benign, atypical, suspicious of malignancy, or malignant, with associated risks of malignancy. Cytological features and management recommendations are provided for each category. The goal is to link cytology reports to optimal breast care.
Giant cell lesions of bone include both reactive and neoplastic conditions characterized by the presence of multinucleated giant cells. Reactive giant cell lesions include giant cell reparative granuloma and brown tumor of hyperparathyroidism. Benign neoplastic giant cell lesions include giant cell tumor and aneurysmal bone cyst. Giant cell tumor is the most common, occurring most frequently in long bones of the extremities in young and middle aged adults. Histologically it is characterized by uniformly distributed osteoclast-like giant cells and mononuclear stromal cells that express RANKL.
This slide presentation summarizes the cytology findings of a liver biopsy from a 60-year-old male. Giemsa stained smears showed moderately cellular tumor cells arranged in clusters and fragments with ill-defined edges. The tumor cells had round to oval nuclei and granular cytoplasm. Background showed lymphocytes and hemorrhage. A diagnosis of metastatic tumor was made, with the top differential diagnoses being metastatic papillary urothelial carcinoma, neuroendocrine tumor, solid pseudo-papillary neoplasm of the pancreas, or epithelioid gastrointestinal stromal tumor. Additional slides showed examples of various liver lesions and metastases that can present on cytology to aid in diagnosis.
The document discusses testicular biopsy and interpretation. It provides details on:
- The structure and layers of the normal testis
- The cells present within the seminiferous tubules including Sertoli cells, spermatogonia, and spermatocytes
- Indications for testicular biopsy including male infertility and controversial role in testicular cancer
- Techniques for testicular biopsy including open surgical and percutaneous methods
- Patterns seen in infertile males such as maturation arrest, Sertoli cell only syndrome, and hypospermatogenesis
The Paris System for Reporting Urinary CytologyRawa Muhsin
The Paris System for Reporting Urinary Cytology provides standardized diagnostic categories for urine cytology specimens. It divides results into negative for high-grade urothelial carcinoma, positive for high-grade urothelial carcinoma, atypical urothelial cells, and suspicious for high-grade urothelial carcinoma based on the number and features of abnormal cells seen. The system aims to determine whether high-grade urothelial carcinoma is present or not, as this has important implications for patient management and prognosis. Risk of malignancy increases from negative to atypical to suspicious to positive categories.
The document discusses the development and benefits of the Milan System for Reporting Salivary Gland Cytopathology. It aims to standardize terminology for salivary gland FNA reports which previously lacked uniformity. The system categorizes specimens as non-diagnostic, non-neoplastic, atypia of undetermined significance, neoplastic (benign or uncertain malignant potential), suspicious for malignancy, or malignant. It is intended to improve communication between pathologists and clinicians, enhance patient care, and facilitate research by allowing standardized data collection across institutions. While validation is ongoing, the system provides a practical framework for uniform reporting of salivary gland cytology.
This document summarizes key information about major and minor salivary glands including their location and cell types. It describes common benign and malignant epithelial tumors of the salivary glands such as pleomorphic adenoma, Warthin's tumor, oncocytoma, and mucoepidermoid carcinoma. For each tumor, the clinical features, microscopic appearance, differential diagnosis, and important histological characteristics are outlined. The document provides an overview of salivary gland anatomy, histology, and the spectrum of tumors that can arise in these glands.
The document discusses recent updates in the diagnosis and grading of prostatic carcinoma, including revisions to Gleason scoring guidelines regarding lesions like cribriform and intraductal carcinoma. It also reviews the role of immunohistochemistry and molecular markers in prognostication as well as emerging applications of artificial intelligence in prostate cancer diagnosis.
The document summarizes the International Academy of Cytology (IAC) System for classifying breast malignancy based on fine-needle aspiration cytology (FNAC) results. The system was developed at a meeting in Yokohama in 2016. It aims to standardize breast cytology reporting to improve diagnosis and patient management. The system categorizes FNAC results as insufficient, benign, atypical, suspicious of malignancy, or malignant, with associated risks of malignancy. Cytological features and management recommendations are provided for each category. The goal is to link cytology reports to optimal breast care.
Giant cell lesions of bone include both reactive and neoplastic conditions characterized by the presence of multinucleated giant cells. Reactive giant cell lesions include giant cell reparative granuloma and brown tumor of hyperparathyroidism. Benign neoplastic giant cell lesions include giant cell tumor and aneurysmal bone cyst. Giant cell tumor is the most common, occurring most frequently in long bones of the extremities in young and middle aged adults. Histologically it is characterized by uniformly distributed osteoclast-like giant cells and mononuclear stromal cells that express RANKL.
This slide presentation summarizes the cytology findings of a liver biopsy from a 60-year-old male. Giemsa stained smears showed moderately cellular tumor cells arranged in clusters and fragments with ill-defined edges. The tumor cells had round to oval nuclei and granular cytoplasm. Background showed lymphocytes and hemorrhage. A diagnosis of metastatic tumor was made, with the top differential diagnoses being metastatic papillary urothelial carcinoma, neuroendocrine tumor, solid pseudo-papillary neoplasm of the pancreas, or epithelioid gastrointestinal stromal tumor. Additional slides showed examples of various liver lesions and metastases that can present on cytology to aid in diagnosis.
The document discusses testicular biopsy and interpretation. It provides details on:
- The structure and layers of the normal testis
- The cells present within the seminiferous tubules including Sertoli cells, spermatogonia, and spermatocytes
- Indications for testicular biopsy including male infertility and controversial role in testicular cancer
- Techniques for testicular biopsy including open surgical and percutaneous methods
- Patterns seen in infertile males such as maturation arrest, Sertoli cell only syndrome, and hypospermatogenesis
The Paris System for Reporting Urinary CytologyRawa Muhsin
The Paris System for Reporting Urinary Cytology provides standardized diagnostic categories for urine cytology specimens. It divides results into negative for high-grade urothelial carcinoma, positive for high-grade urothelial carcinoma, atypical urothelial cells, and suspicious for high-grade urothelial carcinoma based on the number and features of abnormal cells seen. The system aims to determine whether high-grade urothelial carcinoma is present or not, as this has important implications for patient management and prognosis. Risk of malignancy increases from negative to atypical to suspicious to positive categories.
This document provides an approach for evaluating undifferentiated tumors. It begins by categorizing undifferentiated tumors into 4 groups based on morphology: small round cell tumors, epithelioid cell tumors, spindle cell tumors, and pleomorphic tumors. It then outlines the diagnostic algorithm which involves determining the main lineage (epithelial, melanocytic, hematopoietic/lymphoid, or mesenchymal), specifying a diagnosis using immunohistochemistry and clinical correlation, and considering the differential diagnoses for each category. A variety of immunohistochemical markers are also described that can help identify the cell or tumor type.
The document provides an outline and overview of a presentation on cytopathology of the breast. It discusses the normal breast anatomy and cells seen on fine needle aspiration (FNA). It covers patient workup, techniques for FNA, and considerations for interpreting results. Inflammatory conditions, benign and malignant breast tumors are addressed. The accuracy and limitations of FNA are summarized. Reporting categories for breast FNA results are also outlined.
This document discusses various types of liver lesions including regenerative nodules, dysplastic nodules, hepatocellular adenoma, focal nodular hyperplasia, and hepatocellular carcinoma. It provides details on the histological and immunohistochemical features that can help differentiate these lesions. Key points include that dysplastic nodules are believed to be HCC precursors, hepatocellular adenomas can be single or multifocal and classified based on molecular features, and the distinction between well-differentiated HCC and hepatocellular adenoma can be challenging based on overlapping histological features alone.
This document provides an overview of Hodgkin lymphoma, including its normal structure and histology, WHO classification, and subtypes. It discusses the pathogenesis and epidemiology of Hodgkin lymphoma, describing the four main subtypes of classical Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma. Key features of each subtype are summarized, along with diagnostic criteria and differential diagnoses. Prognosis and management are also briefly covered.
The document discusses minimal residual disease (MRD), which refers to small amounts of malignant cells that remain undetectable by conventional methods but can be detected using highly sensitive techniques like PCR. It provides an overview of techniques used for MRD detection in various hematologic malignancies, including morphology, immunophenotyping, cytogenetics, FISH, and PCR. The sensitivity and limitations of each technique is reviewed. Common genomic targets for MRD detection are discussed for several leukemias and lymphomas. The significance of accurately measuring MRD levels for prognosis, monitoring relapse risk, and guiding treatment is also summarized.
This document discusses the use of immunohistochemistry in breast pathology. It covers several topics:
1. Analyzing prognostic markers like hormone receptors in breast cancer and their predictive value.
2. Using myoepithelial cell markers to help solve diagnostic dilemmas and distinguish lesions.
3. Identifying tumor subtypes and assessing diagnoses using markers like luminal vs basal.
4. Evaluating cell populations in proliferative breast lesions and assessing neoplasia vs hyperplasia.
The document discusses the thyroid FNA procedure and diagnostic categories. It provides details on:
- Performing thyroid FNA under ultrasound guidance using a 25 gauge needle with 3-4 passes.
- Preparing direct smears, cytospins, cell blocks and liquid-based preparations from the aspirated material.
- The Bethesda system for reporting thyroid cytopathology which includes 6 diagnostic categories and their associated cancer risks to guide clinical management.
- Key cytologic features that help diagnose common thyroid lesions and cancers.
Minimal Residual Disease in Acute lymphoblastic leukemiaDr. Liza Bulsara
This document discusses minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL). It provides information on several key points:
1. MRD refers to small amounts of leukemia cells that can be detected through sensitive laboratory techniques like flow cytometry and PCR, but not through standard morphology.
2. Various methods for detecting MRD are discussed, including immunophenotyping, PCR, FISH, and cytogenetics. PCR can detect a single malignant cell among 100,000 normal cells and is the most sensitive method.
3. MRD levels determined at different time points during treatment have prognostic significance and can be used for risk stratification and determining the need for treatment intensification or reduction. Monitoring
History of DICER1 mutation
DICER1 function
Mutated DICER1 – tumorigenic mechanism
Constellation of lesions associated with DICER1
DICER1 IHC
When to test?
Therapeutic options
Prognostic & predictive factors of breast cancerMohammed Fathy
1) Prognostic factors provide information about a patient's outcome without treatment, while predictive factors provide information about how a patient may respond to a specific treatment.
2) Many clinical factors, pathological features, tissue markers, and genomic expression profiles can provide prognostic and predictive information for breast cancer patients.
3) Key prognostic factors include age, tumor stage, tumor size, nodal involvement, histological grade, hormone receptor status, and intrinsic subtypes. Predictive factors include hormone receptor and HER2 status.
This document summarizes key information about renal biopsies and nephrectomies:
1) Renal biopsies are typically performed under ultrasound guidance by a nephrologist and radiologist to evaluate renal function abnormalities. Adequate biopsy specimens contain at least 10 glomeruli and two arteries. Tissue is processed for light microscopy, immunofluorescence, and electron microscopy.
2) Nephrectomies are performed for renal tumors, nonfunctioning transplants, or native kidneys. Radical nephrectomies remove the entire kidney and surrounding tissues while partial nephrectomies resect tumors. Specimens are examined grossly and microscopically, with sections
Classification and diagnostic approach to fnac of mediastinalIndira Shastry
This document discusses the classification and diagnostic approach to fine needle aspiration cytology (FNAC) of mediastinal tumors. It describes the various tumor types that can occur in the mediastinum, including thymic tumors, germ cell tumors, lymphomas, and others. For each tumor type, it provides details on cytological features, differential diagnoses, immunohistochemistry findings, and other diagnostic information useful for FNAC-based diagnosis of mediastinal masses. The goal is to simplify the classification and provide guidance on distinguishing between benign and malignant mediastinal tumors using cytology samples.
This document provides guidance on the pathological assessment of colorectal resection specimens. It describes the different types of colorectal surgery specimens and margins that need assessment. It discusses the total mesorectal excision technique for rectal cancers and how to evaluate the quality of the surgery. Key pathological features that require reporting are described, including tumor staging, lymphovascular invasion, perineural invasion, tumor budding and tumor deposits. The document provides details on lymph node assessment and reporting colorectal cancers using a synoptic format.
Testicular lymphoma is a rare form of non-Hodgkin's lymphoma that accounts for 5% of testicular neoplasms. It most commonly presents as a painless testicular mass in elderly men over age 60. Bilateral involvement occurs in 35% of cases. Staging involves PET-CT, bone marrow biopsy, and CSF analysis. Treatment depends on stage - stage I and II receive chemotherapy and scrotal radiotherapy while stage III and IV receive chemotherapy plus intrathecal methotrexate. Prognosis is generally poor due to the tendency for systemic dissemination and relapse years later.
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREASTDrAnkitaPatel
This document discusses various prognostic and predictive factors in breast cancer. It is divided into three categories:
Category I factors that are proven to be prognostically important and useful in clinical management, including tumor size, lymph node status, histological grade, and hormone receptor status.
Category II factors that are extensively studied biologically but require further validation, such as HER2 status, p53 mutation, and lymphovascular invasion.
Category III factors that are not sufficiently studied to demonstrate prognostic value, including tumor angiogenesis and EGFR. Various biomarkers and assays used to evaluate these factors are also described.
The thyroid gland is located in the neck and is composed of two lobes connected by an isthmus. It contains follicles lined by follicular cells that secrete thyroid hormones. Parafollicular cells secrete calcitonin. Fine needle aspiration cytology is used to evaluate thyroid nodules and can identify normal thyroid tissue, non-malignant conditions like goiter and thyroiditis, and malignant tumors including follicular neoplasms, Hurthle cell neoplasms, papillary carcinoma, medullary carcinoma, anaplastic carcinoma, and insular carcinoma based on cellular appearance and arrangement.
Dr shashi bansal approch to bone marrow examinationShashi Bansal
This document provides guidance on performing and interpreting bone marrow examinations. It discusses:
1. The importance of bone marrow examinations for diagnosing blood disorders when other tests are inconclusive.
2. The procedures involved in bone marrow examinations, including aspiration, biopsy, staining, and specialized testing.
3. How to analyze bone marrow samples under the microscope, including identifying cell types, assessing cellularity, iron content, fibrosis, and other features that provide diagnostic information.
Recent updates and reporting of testicular tumors Dr.Argha BaruahArgha Baruah
1) The document discusses recent updates to the classification and reporting of testicular tumors, including changes to the WHO 2016 classification and TNM staging system.
2) Key pathological findings to report include the presence of GCNIS, serum tumor markers, invasion of rete testis, hilar soft tissue, tunica vaginalis, epididymis, and lymphovascular invasion.
3) Adequate sampling from areas of possible extratesticular extension is important for accurate pathological assessment and staging of testicular tumors.
Small round cell tumors are a group of highly aggressive cancers composed of small, undifferentiated cells. The diagnostic approach involves clinical findings, imaging, pathology, and molecular genetics testing. Key small round cell tumors in pediatric patients include Ewing sarcoma, neuroblastoma, nephroblastoma, rhabdomyosarcoma, medulloblastoma, retinoblastoma, and lymphoblastic lymphoma. Immunohistochemistry and genetic testing are used to determine the specific tumor type to help guide treatment.
This document discusses the classification and characteristics of various types of non-Hodgkin lymphoma (NHL). It describes the historical classifications of NHL from the 1940s to the current 2008 WHO classification. It then provides details on specific NHL subtypes, including small lymphocytic lymphoma/chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, and marginal zone B-cell lymphoma. For each subtype, it discusses immunophenotype, genetic abnormalities, clinical features, histopathology, immunostaining patterns, and differential diagnosis.
This document discusses several B cell disorders other than chronic lymphocytic leukemia (CLL) that can involve the blood and bone marrow. These include non-Hodgkin's lymphomas like mantle cell lymphoma, lymphoblastic lymphoma, and marginal zone lymphoma that may present similarly to CLL. It also describes disorders like hairy cell leukemia, lymphoplasmacytic lymphoma, and splenic marginal zone lymphoma that commonly involve the blood. Key diagnostic features of these various disorders are outlined.
This document provides an approach for evaluating undifferentiated tumors. It begins by categorizing undifferentiated tumors into 4 groups based on morphology: small round cell tumors, epithelioid cell tumors, spindle cell tumors, and pleomorphic tumors. It then outlines the diagnostic algorithm which involves determining the main lineage (epithelial, melanocytic, hematopoietic/lymphoid, or mesenchymal), specifying a diagnosis using immunohistochemistry and clinical correlation, and considering the differential diagnoses for each category. A variety of immunohistochemical markers are also described that can help identify the cell or tumor type.
The document provides an outline and overview of a presentation on cytopathology of the breast. It discusses the normal breast anatomy and cells seen on fine needle aspiration (FNA). It covers patient workup, techniques for FNA, and considerations for interpreting results. Inflammatory conditions, benign and malignant breast tumors are addressed. The accuracy and limitations of FNA are summarized. Reporting categories for breast FNA results are also outlined.
This document discusses various types of liver lesions including regenerative nodules, dysplastic nodules, hepatocellular adenoma, focal nodular hyperplasia, and hepatocellular carcinoma. It provides details on the histological and immunohistochemical features that can help differentiate these lesions. Key points include that dysplastic nodules are believed to be HCC precursors, hepatocellular adenomas can be single or multifocal and classified based on molecular features, and the distinction between well-differentiated HCC and hepatocellular adenoma can be challenging based on overlapping histological features alone.
This document provides an overview of Hodgkin lymphoma, including its normal structure and histology, WHO classification, and subtypes. It discusses the pathogenesis and epidemiology of Hodgkin lymphoma, describing the four main subtypes of classical Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma. Key features of each subtype are summarized, along with diagnostic criteria and differential diagnoses. Prognosis and management are also briefly covered.
The document discusses minimal residual disease (MRD), which refers to small amounts of malignant cells that remain undetectable by conventional methods but can be detected using highly sensitive techniques like PCR. It provides an overview of techniques used for MRD detection in various hematologic malignancies, including morphology, immunophenotyping, cytogenetics, FISH, and PCR. The sensitivity and limitations of each technique is reviewed. Common genomic targets for MRD detection are discussed for several leukemias and lymphomas. The significance of accurately measuring MRD levels for prognosis, monitoring relapse risk, and guiding treatment is also summarized.
This document discusses the use of immunohistochemistry in breast pathology. It covers several topics:
1. Analyzing prognostic markers like hormone receptors in breast cancer and their predictive value.
2. Using myoepithelial cell markers to help solve diagnostic dilemmas and distinguish lesions.
3. Identifying tumor subtypes and assessing diagnoses using markers like luminal vs basal.
4. Evaluating cell populations in proliferative breast lesions and assessing neoplasia vs hyperplasia.
The document discusses the thyroid FNA procedure and diagnostic categories. It provides details on:
- Performing thyroid FNA under ultrasound guidance using a 25 gauge needle with 3-4 passes.
- Preparing direct smears, cytospins, cell blocks and liquid-based preparations from the aspirated material.
- The Bethesda system for reporting thyroid cytopathology which includes 6 diagnostic categories and their associated cancer risks to guide clinical management.
- Key cytologic features that help diagnose common thyroid lesions and cancers.
Minimal Residual Disease in Acute lymphoblastic leukemiaDr. Liza Bulsara
This document discusses minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL). It provides information on several key points:
1. MRD refers to small amounts of leukemia cells that can be detected through sensitive laboratory techniques like flow cytometry and PCR, but not through standard morphology.
2. Various methods for detecting MRD are discussed, including immunophenotyping, PCR, FISH, and cytogenetics. PCR can detect a single malignant cell among 100,000 normal cells and is the most sensitive method.
3. MRD levels determined at different time points during treatment have prognostic significance and can be used for risk stratification and determining the need for treatment intensification or reduction. Monitoring
History of DICER1 mutation
DICER1 function
Mutated DICER1 – tumorigenic mechanism
Constellation of lesions associated with DICER1
DICER1 IHC
When to test?
Therapeutic options
Prognostic & predictive factors of breast cancerMohammed Fathy
1) Prognostic factors provide information about a patient's outcome without treatment, while predictive factors provide information about how a patient may respond to a specific treatment.
2) Many clinical factors, pathological features, tissue markers, and genomic expression profiles can provide prognostic and predictive information for breast cancer patients.
3) Key prognostic factors include age, tumor stage, tumor size, nodal involvement, histological grade, hormone receptor status, and intrinsic subtypes. Predictive factors include hormone receptor and HER2 status.
This document summarizes key information about renal biopsies and nephrectomies:
1) Renal biopsies are typically performed under ultrasound guidance by a nephrologist and radiologist to evaluate renal function abnormalities. Adequate biopsy specimens contain at least 10 glomeruli and two arteries. Tissue is processed for light microscopy, immunofluorescence, and electron microscopy.
2) Nephrectomies are performed for renal tumors, nonfunctioning transplants, or native kidneys. Radical nephrectomies remove the entire kidney and surrounding tissues while partial nephrectomies resect tumors. Specimens are examined grossly and microscopically, with sections
Classification and diagnostic approach to fnac of mediastinalIndira Shastry
This document discusses the classification and diagnostic approach to fine needle aspiration cytology (FNAC) of mediastinal tumors. It describes the various tumor types that can occur in the mediastinum, including thymic tumors, germ cell tumors, lymphomas, and others. For each tumor type, it provides details on cytological features, differential diagnoses, immunohistochemistry findings, and other diagnostic information useful for FNAC-based diagnosis of mediastinal masses. The goal is to simplify the classification and provide guidance on distinguishing between benign and malignant mediastinal tumors using cytology samples.
This document provides guidance on the pathological assessment of colorectal resection specimens. It describes the different types of colorectal surgery specimens and margins that need assessment. It discusses the total mesorectal excision technique for rectal cancers and how to evaluate the quality of the surgery. Key pathological features that require reporting are described, including tumor staging, lymphovascular invasion, perineural invasion, tumor budding and tumor deposits. The document provides details on lymph node assessment and reporting colorectal cancers using a synoptic format.
Testicular lymphoma is a rare form of non-Hodgkin's lymphoma that accounts for 5% of testicular neoplasms. It most commonly presents as a painless testicular mass in elderly men over age 60. Bilateral involvement occurs in 35% of cases. Staging involves PET-CT, bone marrow biopsy, and CSF analysis. Treatment depends on stage - stage I and II receive chemotherapy and scrotal radiotherapy while stage III and IV receive chemotherapy plus intrathecal methotrexate. Prognosis is generally poor due to the tendency for systemic dissemination and relapse years later.
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREASTDrAnkitaPatel
This document discusses various prognostic and predictive factors in breast cancer. It is divided into three categories:
Category I factors that are proven to be prognostically important and useful in clinical management, including tumor size, lymph node status, histological grade, and hormone receptor status.
Category II factors that are extensively studied biologically but require further validation, such as HER2 status, p53 mutation, and lymphovascular invasion.
Category III factors that are not sufficiently studied to demonstrate prognostic value, including tumor angiogenesis and EGFR. Various biomarkers and assays used to evaluate these factors are also described.
The thyroid gland is located in the neck and is composed of two lobes connected by an isthmus. It contains follicles lined by follicular cells that secrete thyroid hormones. Parafollicular cells secrete calcitonin. Fine needle aspiration cytology is used to evaluate thyroid nodules and can identify normal thyroid tissue, non-malignant conditions like goiter and thyroiditis, and malignant tumors including follicular neoplasms, Hurthle cell neoplasms, papillary carcinoma, medullary carcinoma, anaplastic carcinoma, and insular carcinoma based on cellular appearance and arrangement.
Dr shashi bansal approch to bone marrow examinationShashi Bansal
This document provides guidance on performing and interpreting bone marrow examinations. It discusses:
1. The importance of bone marrow examinations for diagnosing blood disorders when other tests are inconclusive.
2. The procedures involved in bone marrow examinations, including aspiration, biopsy, staining, and specialized testing.
3. How to analyze bone marrow samples under the microscope, including identifying cell types, assessing cellularity, iron content, fibrosis, and other features that provide diagnostic information.
Recent updates and reporting of testicular tumors Dr.Argha BaruahArgha Baruah
1) The document discusses recent updates to the classification and reporting of testicular tumors, including changes to the WHO 2016 classification and TNM staging system.
2) Key pathological findings to report include the presence of GCNIS, serum tumor markers, invasion of rete testis, hilar soft tissue, tunica vaginalis, epididymis, and lymphovascular invasion.
3) Adequate sampling from areas of possible extratesticular extension is important for accurate pathological assessment and staging of testicular tumors.
Small round cell tumors are a group of highly aggressive cancers composed of small, undifferentiated cells. The diagnostic approach involves clinical findings, imaging, pathology, and molecular genetics testing. Key small round cell tumors in pediatric patients include Ewing sarcoma, neuroblastoma, nephroblastoma, rhabdomyosarcoma, medulloblastoma, retinoblastoma, and lymphoblastic lymphoma. Immunohistochemistry and genetic testing are used to determine the specific tumor type to help guide treatment.
This document discusses the classification and characteristics of various types of non-Hodgkin lymphoma (NHL). It describes the historical classifications of NHL from the 1940s to the current 2008 WHO classification. It then provides details on specific NHL subtypes, including small lymphocytic lymphoma/chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, and marginal zone B-cell lymphoma. For each subtype, it discusses immunophenotype, genetic abnormalities, clinical features, histopathology, immunostaining patterns, and differential diagnosis.
This document discusses several B cell disorders other than chronic lymphocytic leukemia (CLL) that can involve the blood and bone marrow. These include non-Hodgkin's lymphomas like mantle cell lymphoma, lymphoblastic lymphoma, and marginal zone lymphoma that may present similarly to CLL. It also describes disorders like hairy cell leukemia, lymphoplasmacytic lymphoma, and splenic marginal zone lymphoma that commonly involve the blood. Key diagnostic features of these various disorders are outlined.
This slide presentation summarizes the case of a 50-year-old man with fatigue and weight loss who was found to have lymphocytosis, anemia, hepatosplenomegaly, and lymphadenopathy. Peripheral blood smear, bone marrow biopsy, flow cytometry and cytogenetic testing supported a diagnosis of chronic lymphocytic leukemia (CLL) stage III. He was started on chemoimmunotherapy but did not improve, so he was considered for bone marrow transplantation. The presentation provides details on the epidemiology, clinical features, diagnostic criteria, prognostic factors, treatment approaches and histological transformation of CLL.
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma in the United States, arising from germinal center B cells. It is characterized by a translocation involving BCL2, leading to overexpression of the BCL2 protein and promotion of cell survival. While often following an indolent course, transformation to aggressive diffuse large B-cell lymphoma can occur in 30-50% of cases, with reduced survival.
- A 55-year-old male presented with peripheral and central lymphadenopathy and splenomegaly but was asymptomatic. A lymph node biopsy was performed.
- Microscopic examination revealed features consistent with follicular lymphoma (FL), a neoplasm composed of follicle center B-cells which usually has at least a partially follicular pattern. FL is characterized by t(14;18) translocation and involves bone marrow in 40-70% of cases.
- FL was further classified based on the number of centroblasts per high power field according to the Mann and Berard grading system into Grade I (0-5 centroblasts/HPF), Grade II (6-15 centroblasts/
This document discusses the classification and diagnosis of non-Hodgkin lymphoma (NHL) using cytology. It begins by outlining the WHO classification system for lymphomas which incorporates cytology, immunophenotype, genetics, and clinical findings. Flow cytometry is the main diagnostic tool for NHL classification. The document then describes the normal histology and cytology of lymph nodes before focusing on the cytological features and immunophenotypes of common B-cell and T-cell NHL subtypes such as follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma. Accurate classification requires integrating cytological findings with immunophenotyping and genetics.
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the proliferation of immature lymphocytes in the bone marrow. Diagnosis requires identifying at least 20% lymphoblasts in the bone marrow. Testing includes bone marrow biopsy and aspiration with immunophenotyping, cytogenetics, lumbar puncture and other studies. Proper classification is important for determining prognosis and selecting optimal treatment strategies.
Leukemia is a group of blood cancers that begin in the bone marrow and result in abnormal blood cells. The most common types are acute lymphoblastic leukemia (ALL) in children and chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) in adults. Treatment involves chemotherapy, targeted therapy, radiation therapy, bone marrow transplant, immunotherapy or CAR-T cell therapy to kill leukemia cells and achieve remission in phases including induction, consolidation, and maintenance therapy.
Acute leukemias are malignant clonal disorders characterized by excessive proliferation of immature white blood cells in the bone marrow. They are classified as either acute myeloid leukemia (AML) involving the myeloid cell line or acute lymphoblastic leukemia (ALL) involving the lymphoid cell line. AML is further classified by the French-American-British system into eight subtypes (M0-M7) based on morphology and cytochemistry. The World Health Organization classification system incorporates cytogenetic and molecular genetic abnormalities into the classification of AML. Acute leukemias have heterogeneous causes including genetic syndromes, ionizing radiation, chemicals, and viruses.
This document discusses the diagnostic approach and classification of nodal T-cell lymphomas. It notes that T-cell lymphomas represent a higher proportion of non-Hodgkin lymphomas in Asia compared to Western countries. Peripheral T-cell lymphomas originate from mature T lymphocytes and include several subtypes like PTCL-NOS and angioimmunoblastic T-cell lymphoma. It provides details on the clinical features, pathology, immunophenotype, genetics, and prognosis of PTCL-NOS and AITL.
This document provides an overview of chronic lymphocytic leukemia (CLL). It defines CLL as the accumulation of mature B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. CLL most commonly affects older adults and has an unknown cause. The document outlines the clinical presentation, diagnostic criteria, staging systems, complications, treatment approaches, and poor prognostic factors of CLL. It also discusses new therapies that aim to induce complete remission and eliminate minimal residual disease to improve survival outcomes in CLL patients.
The 2016 revision of the WHO classification of lymphoid neoplasms made several important changes compared to the previous 2008 classification. For chronic lymphocytic leukemia/small lymphocytic lymphoma, it clarified the concept of monoclonal B-cell lymphocytosis as a precursor lesion. For follicular lymphoma, it introduced the terminology of pediatric-type follicular lymphoma and duodenal-type follicular lymphoma. For mantle cell lymphoma, it described the role of SOX11 overexpression and identified CCND2 translocations in cyclin D1-negative cases. It also provided updates for other lymphomas such as diffuse large B-cell lymphoma.
Leukemia are neoplastic disorders of the hematopoietic system characterized by aberrant or arrested differentiation. There are two main types - acute and chronic leukemias. Acute leukemias are further classified as myeloid or lymphoid based on the lineage of the malignant cells. Chromosomal abnormalities are detected in the majority of acute leukemia cases and correlate with specific disease subtypes and clinical outcomes. Treatment involves induction chemotherapy followed by consolidation therapy and stem cell transplantation for eligible patients, with cure rates varying based on disease risk factors.
This document summarizes the major changes in the 2016 revision of the World Health Organization classification of hematological malignancies, with a focus on lymphoid neoplasms. Key changes include: refining diagnostic criteria for several entities based on new genetic and molecular data; recognizing new provisional entities; emphasizing distinct subtypes within certain lymphomas that have different clinical behaviors and molecular profiles; and clarifying the definitions of certain pre-malignant conditions. The revision aims to improve diagnosis and help guide treatment strategies based on the most up-to-date understanding of these diseases.
Chemotherapy and radiotherapy play important roles in treating non-Hodgkin lymphoma (NHL). Chemotherapy involves using drugs like cyclophosphamide, doxorubicin, vincristine, and prednisone in combination (e.g. CHOP regimen), often with the addition of rituximab (RCHOP). Radiotherapy uses radiation to kill cancer cells and may be applied to specific areas or the whole body. Current treatment commonly includes 3-8 cycles of RCHOP followed by radiotherapy with doses of 30-36Gy. Radiotherapy is also used palliatively for symptom control in advanced NHL.
Mr. Salim, a 62-year-old man, presented with right neck and left groin swelling for 3 months along with 7-8 kg of weight loss. Biopsy revealed diffuse large B-cell non-Hodgkin lymphoma (NHL). He was diagnosed with stage IV NHL and treated with rituximab and CHOP chemotherapy. The presentation discusses lymphadenopathy causes, lymphoma types and differences between Hodgkin and non-Hodgkin lymphomas, risk factors, investigations and treatments. Key points include distinguishing reactive from tumoral lymph nodes, indolent versus aggressive NHL subtypes, common genetic abnormalities in lymphomas, and involvement of Epstein-Barr virus in certain malignancies.
Non hodgkins lymphomas are of two cell types
T-cells
And B-cells
T-cells constitute only 10% of all Non-hodgkins lymphomas.
T cell lymphomas
Basic introduction of the T -cells-development , maturation and functions.
Cell of origin of various nodal and extranodal lymphomas
WHO classification revised 4th edition
Precursor lymphomas-
T-cell prolymphoblastic leukemia/lymphoma
Nodal lymphomas - Angioimmunoblastic lymphoma
Anaplastic lymphoma (ALK+&ALK-)
Peripheral T cell lymphoma - NOS
Extranodal lymphomas-
EN-Nk T-cell lymphoma nasal type
Intestinal lymphomas
EATL
METL
Hepatosplenic lymphoma
Leukemic lymphomas
Adult T cell leukemia
T-cell prolymphocytic leukemia
T cell large granular lymphocytic leukemia
Cutaneous lymphomas
Mycosis fungoides
Sezary syndrome
Summary:
CD8+/CD4- in Extranodal lymphomas: Hepatosplenic lymphomas, MEITL, T-LGL
CD4+/CD8- with diffuse CD30+ is ALCL .
CD4+/CD8- with TFH and TF dendritic markers + is AITL.
CD4+/CD8- with HTLV exposure is ATLL.
CD4+/CD8- with loss of CD7 with cutaneous manifestations+ epidermotropism+spongiosis is Mycosis fungoides.
Waste basket category is PTCL-NOS
CD4+CD8-CD10-PD1- with lymphocytosis is T-PLL
References
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature-appearing B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. It is considered a clonal B cell malignancy caused by a defect in apoptosis that allows long-lived, non-cycling lymphocytes to accumulate over time. CLL cells typically express CD5, CD19, and CD23 and have mutations that dysregulate pathways controlling cell survival and apoptosis. Prognosis depends on clinical features and genetic abnormalities - deletion of 13q or mutated IgVH correlate with better prognosis while deletion of 11q or 17p indicate poorer prognosis. CLL can transform into an aggressive lymphoma called Richter's syndrome over time.
The document discusses testicular tumors, providing details on:
1) Germ cell tumors (seminomas and nonseminomas) account for 95% of testicular tumors and can spread rapidly.
2) Sex cord-stromal tumors include Leydig cell and Sertoli cell tumors.
3) Risk factors for germ cell tumors include cryptorchidism, pesticide exposure, and genetic factors. Tumor markers like HCG, AFP, and LDH help diagnose and monitor these cancers.
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
Assessment and Planning in Educational technology.pptxKavitha Krishnan
In an education system, it is understood that assessment is only for the students, but on the other hand, the Assessment of teachers is also an important aspect of the education system that ensures teachers are providing high-quality instruction to students. The assessment process can be used to provide feedback and support for professional development, to inform decisions about teacher retention or promotion, or to evaluate teacher effectiveness for accountability purposes.
2. Lymphoma involving Testis
• Introduction
• Testis Diffuse large B cell lymphoma(T-DLBCL)
• Other high grade B cell lyphoma
• Testis Follicular lymphoma(T-FL)
• Other low grade B cell lymphoma
• NK/T cell lymphoma
• Differential Diagnosis
• Key Points
Dr Ravi Kothari
3. Introduction
• Uncommon site(1-2%) , 5% of all testicular
tumors.
• More common in younger then older men.
• However in Men > 50 yrs lymphoma is most
common testicular tumors.
• Most common - Diffuse large B cell
lymphoma(DLBCL)
• DLBCL (80-90%) > Follicular lymphoma(FL)
(2%) > NHL
Dr Ravi Kothari
4. Testis Diffuse large B cell lymphoma
(T-DLBCL)
• Common in older, Mean age – 60 yrs.
• Can be seen in yonger, risk factor – HIV.
• White Men > Black
• The testis and central nervous system (CNS)
have been regarded as immune- privileged
sites. Testicular DLBCL shares many features
(i.e. immunophenotype, genetic and
molecular) with primary CNS large B-cell
lymphoma.
Dr Ravi Kothari
5. Pathogenesis
• Immune escape
• Loss of HLA gene which leads to reduced
expression of MHC 1 & 2.
• Other frequent abnormalities include gains
and amplifications of 9p24.1 locus which lead
to increased expression of PD-L1 and PD-L2
proteins and contribute to evasion of an anti-
tumour immune response.
Dr Ravi Kothari
6. Clinical Features
• Firm painless scrotal mass.
• 10-15% B/L.
• 50% localized to testis (Stage I)
• Can involve LN & extranodal.
• In 30% CNS involvement.
• 20-30% shows B symptoms (fever, night sweat,
wt. loss)
Dr Ravi Kothari
7. Diagnosis
Prophylactic Treatment
CNS targeted immuno-chemotherapy Contralateral orchidectomy
Check CNS involvement
Imaging CSF immunophenotyping
Initial diagnosis on orchidectomy specimen
Stagging by PET Check Contralateral Testis
Prognosis
•More aggressive than DLBCL NOS
•Low clinical stage – better prognosis
•CNS involvement – poor prognosis
Dr Ravi Kothari
8. Gross
• T-DLBCL frequently replaces most of the testicular
parenchyma (average size approximately 6 cm),
• invades tunica albuginea, usually involves epididymis, and
sometimes the spermatic cord.
• The lymphoma is usually fleshy, tan or pinkish in colour
with a uniform appearance on cut surface (Figure 10.1).
Dr Ravi Kothari
9. Microscopy
• the testicular parenchyma is diffusely infiltrated by lymphoma cells with
either complete obliteration of the normal architecture or percolation in-
between the seminiferous tubules.
• Lymphoma cells typically invade and fill the seminiferous tubules, often
displacing or replacing the germ and Sertoli cells.
• The cells are large, and exhibit features consistent with centroblasts
(round nuclei, several peripherally located nucleoli), or less commonly
immunoblasts (central nucleoli) (Figure 10.2).
10. IHC
• Positive – Pan B cell markers(CD19, CD20, CD 79a,
PAX 5)
• Negative – CD 10 , BCL6; MUM1- Positive.
• Rarely CD 10 Positive – Secondary involvement of
Testis.
• BCL2 expression seen.
• Ki 67 index high(>70%)
• OCT4 positive in 18%, DD of Seminoma
Dr Ravi Kothari
11. Other high grade lymphomas involving Testis
• Plasmablastic lymphoma
• Burkitt’s lymphoma
• B lymphoblastic leukemia/lymphoma(B-ALL)
Dr Ravi Kothari
12. Plasmablastic lymphoma
• Reported in HIV-positive with EBV infection as well as HIV-
negative patients.
• Aggressive lymphoma that frequently occurs in HIV-infected
individuals.
• Site : oral cavity (MC) > gastrointestinal tract; patients
frequently present with disseminated (stage III/IV) disease.
• Two reported cases in HIV-positive patients interestingly
documented the testis as the primary site of disease.
• a lymphoma that consists of immunoblastic/plasmablastic
cells with prominent central nucleoli.
• Plasma cell like IHC
Positive for CD138, CD38, and MUMI.
Usually negative or weakly positive for B-cell markers (CD20
and PAXS).
Dr Ravi Kothari
13. Burkitt lymphoma
• mostly as a part of a systemic disease and very
rarely as an isolated/primary site of involvement.
• Majority in Children.
• Aggressive but curable lymphoma if treated with
intensive chemotherapy regimens.
• 3 clinical subtypes endemic (seen mainly in
equatorial Africa), sporadic and
immunodeficiency associated, which is seen most
commonly in HIV-positive individuals.
Dr Ravi Kothari
14. Burkitt lymphoma
• Diffuse infiltrate of monotonous medium-sized
lymphoma cells with fine chromatin and small nucleoli.
• Scattered tingible-body macrophages impart the so-
called “starry- sky appearance.”
• Positivity for pan B-cell markers, CD10, BCL6, and MYC
protein.
• BCL2 is typically negative.
• Moreover, the proliferation index (by Ki67
immunostaining) approaches 100%. The signature
genetic abnormality in Burkitt lymphoma is the
translocation of the MYC gene (8q24) to the IGH
(14432)-(8:14).
Dr Ravi Kothari
15. B-lymphoblastic
leukaemia/lymphoma (B-ALL)
• Testicular involvement at diagnosis is mainly seen in
young boys in 1.2-2.4% of cases but is very rare in adult
men
• Morphologically. B-ALL shows diffuse testicular
involvement by sheets of blasts with displacement of
seminiferous tubules (Figure 10.4).
• Positive for B-cell markers including CD19, cCD79a, and
cCD22. Other CD10 and TdT.
• CD34 and CD20 show variable expression.
• Cytogenetic and molecular studies are routinely done
in all cases of B-ALL at the time of diagnosis for further
risk stratification and treatment planning
Dr Ravi Kothari
16. Follicular lymphoma
• Compared to conventional FL, T-FL is rare. few
small series and single case reports published.
• Most of the reported patients are children and
young adults, but there are rare reports of this
tumour arising in older men.
• T-FL is typically localised to testis (stage IE).
• Most patients received chemotherapy but
some only underwent surgical excision. The
prognosis is excellent.
Dr Ravi Kothari
17. Follicular lymphoma
• Morphologically, the testis and frequently the epididymis are
involved by atypical vague nodules/follicles composed of a mixture
of centrocytes and centroblasts. Most cases are grade 3A.
• The lymphoma either completely obliterates the architecture or
infiltrates in between seminiferous tubules, efferent ductules or
epididymal tubules. Extension into the tunica albuginea or the
spermatic cord is sometimes seen. Small centrocytic lymphoma
cells, admixed with small lymphocytes, plasma cells, and occasional
eosinophils can be seen outside of neoplastic follicles, frequently in
a peritubular distribution (Figure 10.5).
• Some cases contain small clusters or sheets of large cells
(centroblasts) outside of the follicles, consistent with areas of
diffuse large B-cell lymphoma.
Dr Ravi Kothari
18. Follicular lymphoma
• Positive for pan B-cell markers (CD20, CD19,
CD79a, and PAX5), BCL6, and CD10.
• Compared to conventional FL., T-FL. is usually
negative for BCL2 (Figure 10.6).
• Primary T-FL is rare but important entity to
recognise since most patients have an
excellent prognosis.
Dr Ravi Kothari
19.
20. Other low-grade B-cell lymphomas
involving the testis
• Various low-grade B-cell lymphomas can
involve the testis, usually as part of a systemic
disease, and rarely as a primary or isolated
disease site. Similar to the higher grade B-cell
lymphomas, complete clinical, laboratory and
radiologic staging is needed to evaluate the
extent of disease.
Dr Ravi Kothari
21. Other low-grade B-cell lymphomas
involving the testis
• An FL of conventional type was reported in the testis.
In comparison to T-FL described above, this particular
case showed extensive systemic disease, was grade 1
histologically, and expressed BCL2.
• Chronic lymphocytic leukaemia/small lymphocytic
lymphoma (CLL/SLL) can involve a variety of extra-
nodal sites, including the skin, gastrointestinal the
frequency of testicular involvement is difficult to
estimate.
• An interesting case of a 72-year-old man with testicular
involvement by CLL/SLL transforming into DLBCL (so-
called "Richter transformation")
Dr Ravi Kothari
22. Other low-grade B-cell lymphomas
involving the testis
• We have encountered a case of mantle cell
lymphoma that involved the testis in a nodular
pattern (Figure 10.8).
• Plasma cell neoplasms
• NK/T-cell lymphomas involving the testis
• peripheral T-cell lymphoma
• anaplastic large cell lymphoma
• T-lymphoblastic lymphoma
Dr Ravi Kothari
24. Plasma cell neoplasms
• involve the testis, either as part of systemic disease in
plasma cell myeloma, or as solitary site of involvement
(i.e. extramedullary plasmacytoma).
• Histologically, these lesions appear as a diffuse
infiltrate of plasma cells with varying degree of atypia.
The plasma cells are positive for CD138 and show x or λ
light chain restriction.
• These neoplasms, when diagnosed in the absence of a
previous clinical history of plasma cell myeloma, are
best called "plasma cell neoplasms"
Dr Ravi Kothari
25. NK/T-cell lymphomas involving the
testis
• Comprise approximately 15% of non-Hodgkin lymphomas,
somewhat more common in Asian countries.
• These rare lymphomas can occur in very uncommon sites
such as the testis where they can pose a significant
diagnostic challenge even for seasoned lymphoma
pathologists.
• As emphasised with B-cell neoplasms, when NK-/T-cell
lymphomas disease. are diagnosed in the testis, clinical
staging is needed to evaluate for systemic Extranodal NK/T-
cell lymphoma (ENKTCL), nasal type is the only lymphoma
from this group that can occur as a primary testicular
lymphoma.
Dr Ravi Kothari
26. NK/T-cell lymphomas involving the
testis
• The lymphoma cell infiltrate is diffuse. frequently
obliterating seminiferous tubules.
• Angioinvasion, neural invasion and necrosis are
commonly seen. Lymphoma cells vary from small to
large and may be even anaplastic.
• lymphoma cells are positive for cytoplasmic CD3-
epsilon (surface CD3 is negative), CD56, CD2, and
cytotoxic molecules (TIA-1. granzyme B and perforin).
• In rare cases that show cytotoxic T-cell and not NK-cell
origin, lymphoma cells are positive for CD8, CD5 and T-
cell receptor (TCR) a and ẞ ory and 5.
• always positive for the EBV.
Dr Ravi Kothari
27. NK/T-cell lymphomas involving the
testis
• Clinically, ENKTCL are aggressive lymphomas
that require multimodal treatment approach
(i.e. surgery, radiation, and chemotherapy).
• Patients with testicular ENKTCL must be
completely staged with careful examination of
the upper aerodigestive tract, since occult
lymphoma can be found in some cases.
Dr Ravi Kothari
28. Differential diagnosis of testicular
lymphoma
• Seminoma
Rarely, the tumour can be so obscured by the
lymphocyte population, that it can be confused
for a lymphoid neoplasm.
Seminomas are positive for SALL4, CD117, OCT-
4, D2-40 and negative for typical lymphoid
markers (Figure 10.9).
Of note, OCT-4 was reported to stain up to 18%
of T-DLBCL cases which is important to keep in
mind to avoid confusion with germ cell tumour.
Dr Ravi Kothari
29. Differential diagnosis of testicular
lymphoma
• Spermatocytic tumour
usually arises in men older than 45 years of age.
Histologically, these tumours consist of sheets
of variably sized cells with a high nuclear:
cytoplasmic ratio.
spermatocytic tumour are typically negative
for lymphoid markers and are often positive
for CD117 and SALL4.
Dr Ravi Kothari
30. Differential diagnosis of testicular
lymphoma
• Malignant teratomas
can sometimes undergo secondary malignant
transformation to entities such as
rhabdomyosarcoma which could be confused
for a lymphoma.
Unlike lymphomas, these tumours will react
immunohistochemically with antibodies to
desmin, myogenin and MyoD1
Dr Ravi Kothari
31. Differential diagnosis of testicular
lymphoma
• Myeloid sarcoma
a tumour mass consisting of myeloid blasts occurring in
extramedullary location, can occasionally involve the testis.
Morphologically, sheets of usually monotonous blasts, frequently
with monoblastic morphology, are seen. Maturing myeloid
elements are sometimes present, including eosinophilic precursor
which are helpful morphologic 'hint’ Fig 10.12
Myeloid blasts are usually positive for CD33, CD117, CD34, and
MPO.
In monoblastic variant CD68 and CD163 are consistently expressed,
but MPO and CD34 are negative.
Finally, abundant chronic inflammation seen in lymphocytic orchitis
from infection (e.g. viral orchitis) can also mimic a
haematolymphoid neoplasm.
Dr Ravi Kothari
32. Key points
• uncommon testicular tumours,
• most commonly seen in men > 50 years
• Testicular diffuse large B-cell lymphomas accounts for over
80%.
• Testicular follicular lymphoma is a rare tumour that usually
occurs in children and young adults. It is important to
recognise since it carries excellent prognosis even with
conservative therapy.
• Among NK-/T-cell lymphomas, extranodal NK-/T-cell
lymphoma, nasal type can occur as a primary testicular
lymphoma.
• Mimickers of testicular lymphomas include germ-cell
tumours, inflammatory conditions and myeloid sarcoma
Dr Ravi Kothari